Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-04-13 Purchase | 2023-01-20 4:32 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 1,191 | $20.98 | $24,987 | 575,492 (Indirect Direct) | View |
| 2022-01-03 Sale | 2022-01-05 7:14 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $57.84 | $2,756,116 | 232,727 (Indirect) | View |
| 2021-12-01 Sale | 2021-12-03 5:05 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $54.09 | $2,577,376 | 251,536 (Indirect) | View |
| 2021-11-01 Sale | 2021-11-03 7:04 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $42.12 | $2,007,129 | 270,346 (Indirect) | View |
| 2021-10-19 Sale | 2021-10-21 4:29 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 8,598 | $38.2 | $328,441 | 289,156 (Indirect) | View |
| 2021-10-14 Sale | 2021-10-18 8:35 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 26,367 | $38.56 | $1,016,653 | 292,550 (Indirect) | View |
| 2021-10-01 Sale | 2021-10-05 8:47 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 12,686 | $40.1 | $508,755 | 302,958 (Indirect) | View |
| 2021-09-27 Sale | 2021-09-29 4:39 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 95,302 | $41.17 | $3,924,003 | 307,966 (Indirect) | View |
| 2021-07-01 Sale | 2021-07-06 6:02 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,652 | $41.31 | $1,968,352 | 345,585 (Indirect) | View |
| 2021-06-04 Sale | 2021-06-08 4:31 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 19,415 | $49.07 | $952,613 | 364,395 (Indirect) | View |
| 2021-06-01 Sale | 2021-06-03 8:06 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 28,236 | $49.71 | $1,403,553 | 372,059 (Indirect) | View |
| 2021-05-03 Sale | 2021-05-05 5:22 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 47,651 | $57.27 | $2,728,849 | 383,205 (Indirect) | View |
| 2021-04-06 Sale | 2021-04-08 4:35 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 9,298 | $58.81 | $546,840 | 402,015 (Indirect) | View |
| 2021-04-01 Sale | 2021-04-05 9:11 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 38,353 | $59.72 | $2,290,536 | 405,685 (Indirect) | View |
| 2021-03-03 Sale | 2021-03-05 7:44 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 23,959 | $56.45 | $1,352,499 | 420,825 (Indirect) | View |
| 2021-03-01 Sale | 2021-03-03 8:40 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 23,690 | $61.13 | $1,448,078 | 430,283 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-18 6:46 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 28,617 | $60.87 | $1,742,043 | 439,634 (Indirect) | View |
| 2021-02-11 Sale | 2021-02-16 5:50 pm | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 19,029 | $63.53 | $1,208,936 | 450,930 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:42 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:28 pm | N/A 2032-05-31 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:33 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 8,293 | $0 | 8,293 (Direct) | View |
| 2020-04-13 Conversion | 2020-04-13 5:13 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 915,725 | $0 | 458,442 (Indirect) | View |
Ownership | 2020-04-07 7:31 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Knowles Julius Director | 0 | $0 | 1,146,107 (Indirect) | View |